CDY Share Price

Open 0.02 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.02 1 Week 0.01 50.00
Close 0.03 1 Month 0.01 50.00
Volume 758382 1 Year -0.01 -25.00
52 Week High 0.04
52 Week Low 0.02
CDY Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.03
Support 1 0.02
Support 2 0.02
ASX Australia Most Active Stocks
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
DJS 3.99 0.00%
DJS 3.99 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
NGY 0.04 33.33%
ANP 0.04 33.33%
TOE 0.04 33.33%
TOE 0.04 33.33%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
CNX 0.46 -64.62%
CNX 0.46 -64.62%
CNX 0.46 -64.62%
RFT 0.01 -50.00%
GDY 0.01 -50.00%
More..

Cellmid Ltd (ASX: CDY)

CDY Technical Analysis 4
As on 26th Jul 2017 CDY Share Price closed @ 0.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.03 & Strong Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
CDY Target for July
1st Target up-side 0.03
2nd Target up-side 0.03
3rd Target up-side 0.03
1st Target down-side 0.01
2nd Target down-side 0.01
3rd Target down-side 0.01
CDY Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.cellmid.com.au
CDY Address
CDY
Level 18
Suite 1802
Sydney, NSW 2000
Australia
Phone: 61 2 9221 6830
Fax: 61 2 9221 8535
CDY Latest News
Investor Focus on Cellmid Ltd (CDY.AX) Shares   Hayden Business Journal   - 25th Jul 17
Nature Publication Identifies Cellmid Limited's (ASX:CDY) Midkine as Important ...   ABN Newswire (press release)   - 04th Jul 17
Cellmid Limited gets a boost for its midkine assets   Proactive Investors Australia   - 03rd Jul 17
Cellmid launch hair loss product to vast US market   Finfeed (blog)   - 04th Nov 16
Cellmid Ltd launches hair loss products into US$3.5B market   Proactive Investors Australia   - 03rd Nov 16
Cellmid Ltd secures funds to launch hair loss product in US   Proactive Investors Australia   - 01st Nov 16
Cellmid Ltd gets boost from study results treating brain cancer   Proactive Investors Australia   - 05th Oct 16
Cellmid Ltd to enter world's largest hair loss treatment market   Proactive Investors Australia   - 20th Jul 16
Cellmid Limited's CEO Maria Halasz buys shares on-market   Proactive Investors Australia   - 18th Dec 15
Cellmid Limited is a stock on the move   Proactive Investors Australia   - 28th Jul 15
Interactive Technical Analysis Chart Cellmid Ltd ( CDY ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cellmid Ltd
CDY Business Profile
Cellmid Limited, a biotechnology company, is engaged in the development and commercialization of diagnostic and therapeutic products for heart attack, inflammatory diseases, and cancer in Australia. It offers MK ELISA, a sandwich enzyme immunoassay in a 96 well plate format for measuring MK levels in human serum samples. The company’s pipeline diagnostic programs include CAN104, a canine cancer diagnostic product, as well as CS5000 and CK3000, the cancer screening products; and CAMI103, a therapeutic program for heart attack, as well as CAB101, an anti-inflammatory antibody. It also develops and sells FGF-5, an over-the-counter treatment to alleviate excessive and abnormal hair loss and re-establish the natural hair growth cycle; and Évolis, a hair growth tonic for men and women. Cellmid Limited is based in Sydney, Australia.